Rapid review protocol: Zinc for the prevention or treatment of COVID-19 and other coronavirus-related respiratory tract infections.
Coronavirus
Rapid review
Respiratory tract infection
SARS-CoV-2
Zinc
Journal
Integrative medicine research
ISSN: 2213-4220
Titre abrégé: Integr Med Res
Pays: Netherlands
ID NLM: 101612707
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
25
05
2020
revised:
16
06
2020
accepted:
18
06
2020
entrez:
22
7
2020
pubmed:
22
7
2020
medline:
22
7
2020
Statut:
ppublish
Résumé
The global COVID-19 pandemic has prompted an urgent search for effective interventions. SARS-CoV-2 mortality/morbidity risk increases with age and for those chronic disease co-morbidities, both of which are associated with lower zinc status, as is the risk of infection. Rapid review methods will be applied to a systematic review of zinc for the prevention or treatment of SARS-CoV-2 and viral respiratory tract infections in humans. Included are published studies reporting randomised and quasi-randomised controlled trials that compare zinc intervention to placebo and/or other comparator interventions. English and Chinese language databases will be searched for primary studies of viral respiratory tract infections and clinical trial registries for SARS-CoV-2 infections. Due to concerns about indirectness, studies evaluating non-SARS-CoV-2 coronavirus infections will be rated down by one level, and non-specific or confirmed non-coronavirus viral infections will be rated down by two levels. Review constraints include (1) using Google translate when screening articles published in languages other than English or Chinese and limited translation (2) following calibration, only one reviewer will screen articles, extract data, appraise quality and conduct the analysis, (3) prioritising data extraction and meta-analyses of SARS-CoV-2 studies and critical outcomes of other viral infections, followed by high risk groups and (4) reporting important preliminary findings prior to peer review if necessary. The application of these rapid review methods and broadening the inclusion criteria to include other coronavirus-related viral respiratory tract infections aims to enable a timely evidence appraisal of priority research questions and dissemination of results. PROSPERO CRD42020182044.
Sections du résumé
BACKGROUND
BACKGROUND
The global COVID-19 pandemic has prompted an urgent search for effective interventions. SARS-CoV-2 mortality/morbidity risk increases with age and for those chronic disease co-morbidities, both of which are associated with lower zinc status, as is the risk of infection.
METHODS
METHODS
Rapid review methods will be applied to a systematic review of zinc for the prevention or treatment of SARS-CoV-2 and viral respiratory tract infections in humans. Included are published studies reporting randomised and quasi-randomised controlled trials that compare zinc intervention to placebo and/or other comparator interventions. English and Chinese language databases will be searched for primary studies of viral respiratory tract infections and clinical trial registries for SARS-CoV-2 infections. Due to concerns about indirectness, studies evaluating non-SARS-CoV-2 coronavirus infections will be rated down by one level, and non-specific or confirmed non-coronavirus viral infections will be rated down by two levels. Review constraints include (1) using Google translate when screening articles published in languages other than English or Chinese and limited translation (2) following calibration, only one reviewer will screen articles, extract data, appraise quality and conduct the analysis, (3) prioritising data extraction and meta-analyses of SARS-CoV-2 studies and critical outcomes of other viral infections, followed by high risk groups and (4) reporting important preliminary findings prior to peer review if necessary.
DISCUSSION
CONCLUSIONS
The application of these rapid review methods and broadening the inclusion criteria to include other coronavirus-related viral respiratory tract infections aims to enable a timely evidence appraisal of priority research questions and dissemination of results.
STUDY REGISTRATION
BACKGROUND
PROSPERO CRD42020182044.
Identifiants
pubmed: 32690999
doi: 10.1016/j.imr.2020.100457
pii: S2213-4220(20)30089-5
pii: 100457
pmc: PMC7308745
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100457Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V.
Références
BMJ Evid Based Med. 2018 Dec;23(6):201-203
pubmed: 29950313
J Am Diet Assoc. 2001 Mar;101(3):294-301
pubmed: 11269606
Influenza Other Respir Viruses. 2014 Jul;8(4):397-405
pubmed: 24852890
Proc Nutr Soc. 2006 Feb;65(1):51-60
pubmed: 16441944
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
Cochrane Database Syst Rev. 2015 Apr 30;(4):CD001364
pubmed: 25924708
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
J Aging Soc Policy. 2020 Jul-Oct;32(4-5):310-315
pubmed: 32245346
Cochrane Database Syst Rev. 2000;(2):CD001364
pubmed: 10796643
Int J Vitam Nutr Res. 2010 Oct;80(4-5):271-7
pubmed: 21462110
J Nutr. 2007 May;137(5):1345-9
pubmed: 17449604
J Nutr Health Aging. 2005;9(1):45-51
pubmed: 15750665
PLoS One. 2013;8(3):e59202
pubmed: 23544056
J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):594-603
pubmed: 15496046
JRSM Open. 2017 May 02;8(5):2054270417694291
pubmed: 28515951
Am J Respir Crit Care Med. 2013 Sep 15;188(6):716-23
pubmed: 23805851
Biogerontology. 2006 Oct-Dec;7(5-6):421-8
pubmed: 16953331
Am J Physiol Lung Cell Mol Physiol. 2006 Mar;290(3):L433-41
pubmed: 16284213
Am J Clin Nutr. 1998 Aug;68(2 Suppl):488S-494S
pubmed: 9701166
Int J Mol Med. 2020 Jul;46(1):17-26
pubmed: 32319538
Diabetes Metab Res Rev. 2020 Mar 31;:e3319
pubmed: 32233013
BMC Med. 2015 Sep 16;13:224
pubmed: 26377409
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Am Coll Nutr. 1998 Dec;17(6):564-70
pubmed: 9853535
Br J Nutr. 2001 May;85 Suppl 2:S101-8
pubmed: 11509097
Arch Gerontol Geriatr. 2001 Nov-Dec;33(3):243-53
pubmed: 15374021
Annu Rev Nutr. 2004;24:277-98
pubmed: 15189122
Nutr Rev. 1993 Sep;51(9):255-67
pubmed: 8247417
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1699-704
pubmed: 16434472
PLoS One. 2014 Oct 01;9(10):e109180
pubmed: 25271834
J Nutr. 1988 Aug;118(8):995-1001
pubmed: 3404291
Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1132-41
pubmed: 16844947
Mikrobiyol Bul. 2015 Apr;49(2):188-200
pubmed: 26167819
JAMA. 1999 Aug 18;282(7):634-5
pubmed: 10517715
J Sci Food Agric. 2013 Aug 15;93(10):2362-71
pubmed: 23595983
PLoS Pathog. 2010 Nov 04;6(11):e1001176
pubmed: 21079686
J Ren Nutr. 2011 Mar;21(2):184-7
pubmed: 21093288
Am J Clin Nutr. 1988 Nov;48(5):1307-9
pubmed: 3189221
J Nutr. 2002 Nov;132(11):3422-7
pubmed: 12421862
Cochrane Database Syst Rev. 2016 Dec 04;12:CD005978
pubmed: 27915460
PLoS One. 2019 Apr 5;14(4):e0214207
pubmed: 30951544
Proc Soc Exp Biol Med. 1965 May;119:177-80
pubmed: 14297840
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD000980
pubmed: 23440782
Biomed Environ Sci. 2019 Jun;32(6):438-445
pubmed: 31262389
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Am J Clin Nutr. 2007 Oct;86(4):1167-73
pubmed: 17921398
Engineering (Beijing). 2020 Mar 18;:
pubmed: 32292626
Food Nutr Bull. 2009 Mar;30(1 Suppl):S60-78
pubmed: 19472602
Pharmacol Ther. 2005 Feb;105(2):127-49
pubmed: 15670623
J Membr Biol. 1988 Jul;103(1):79-94
pubmed: 2846846
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
J Nutr. 2000 May;130(5S Suppl):1378S-83S
pubmed: 10801947
J Clin Virol. 2018 May;102:27-31
pubmed: 29477833
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Front Pharmacol. 2020 May 25;11:781
pubmed: 32574235
Biochem Pharmacol. 2003 Oct 15;66(8):1459-68
pubmed: 14555222
Am J Clin Nutr. 1989 Dec;50(6):1450-6
pubmed: 2596435
Mil Med Res. 2020 Feb 6;7(1):4
pubmed: 32029004
Crit Care Med. 2019 Oct;47(10):1324-1331
pubmed: 31356474
Biochemistry. 2005 Aug 2;44(30):10349-59
pubmed: 16042412
Med Hypotheses. 1996 Mar;46(3):295-302
pubmed: 8676770
J Nutr. 2000 May;130(5S Suppl):1399S-406S
pubmed: 10801951
Ann Intern Med. 2009 Feb 3;150(3):199-205
pubmed: 19189910
Immunol Cell Biol. 2001 Apr;79(2):170-7
pubmed: 11264713
Cochrane Database Syst Rev. 2013 Jun 18;(6):CD001364
pubmed: 23775705
PLoS One. 2015 Sep 25;10(9):e0138684
pubmed: 26406339
Res Synth Methods. 2011 Sep;2(3):188-203
pubmed: 26061786
J Clin Epidemiol. 2020 May;121:20-28
pubmed: 31972274
Curr Opin Pediatr. 2015 Feb;27(1):110-5
pubmed: 25514574
Diabetes Care. 2007 Mar;30(3):523-8
pubmed: 17327315
J Med Virol. 2009 Apr;81(4):750-6
pubmed: 19235872
BMC Med Res Methodol. 2019 Jun 28;19(1):132
pubmed: 31253092
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
BMC Med Res Methodol. 2013 Aug 30;13:106
pubmed: 24004523